Page last updated: 2024-11-02

piperazine and Diabetic Glomerulosclerosis

piperazine has been researched along with Diabetic Glomerulosclerosis in 4 studies

Research Excerpts

ExcerptRelevanceReference
" It is believed that piperazine ferulate (PF) combined with irbesartan could result in an improved efficacy in the treatment of DN."2.66Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis. ( Li, B; Li, D; Liu, R; Peng, LX; Zeng, N, 2020)
"Piperazine ferulate (PF) has been reported to exert protective effects against the progression of DN."1.62Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66 ( Chen, Z; Deng, RR; Xiang, DX; Yang, XD; Yang, YY; Yao, LY, 2021)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Li, D1
Li, B1
Peng, LX1
Liu, R1
Zeng, N1
Yang, YY2
Deng, RR1
Chen, Z1
Yao, LY2
Yang, XD1
Xiang, DX2
Yang, C1
Yang, W1
Chen, Y1
Cheng, Q1
Chen, W1
Shi, LX1
Li, JH1

Reviews

2 reviews available for piperazine and Diabetic Glomerulosclerosis

ArticleYear
Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis.
    Clinical therapeutics, 2020, Volume: 42, Issue:11

    Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Humans; Irbesartan; Middle Age

2020
Improving renoprotective effects by adding piperazine ferulate and angiotensin receptor blocker in diabetic nephropathy: a meta-analysis of randomized controlled trials.
    International urology and nephrology, 2022, Volume: 54, Issue:2

    Topics: Angiotensin Receptor Antagonists; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Piperaz

2022

Other Studies

2 other studies available for piperazine and Diabetic Glomerulosclerosis

ArticleYear
Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66
    Molecular medicine reports, 2021, Volume: 23, Issue:5

    Topics: Acute Kidney Injury; Animals; Collagen Type IV; Diabetic Nephropathies; Disease Models, Animal; Fibr

2021
Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
    Molecular medicine reports, 2019, Volume: 19, Issue:3

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Ani

2019